mycophenolate mofetil
E1355549
UNEXPLORED
Mycophenolate mofetil is an immunosuppressive medication commonly used to prevent organ transplant rejection and to treat various autoimmune diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| mycophenolate mofetil canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T19040269 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: mycophenolate mofetil Context triple: [GPA, treatedWith, mycophenolate mofetil]
-
A.
cyclosporine A
Cyclosporine A is an immunosuppressant drug widely used to prevent organ transplant rejection and treat certain autoimmune diseases.
-
B.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
C.
methotrexate
Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
-
D.
sulfasalazine
Sulfasalazine is an anti-inflammatory drug commonly used to treat rheumatoid arthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.
-
E.
indoximod
Indoximod is an investigational small-molecule immunotherapy drug that modulates the IDO pathway to enhance anti-tumor immune responses in cancer treatment.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: mycophenolate mofetil Target entity description: Mycophenolate mofetil is an immunosuppressive medication commonly used to prevent organ transplant rejection and to treat various autoimmune diseases.
-
A.
cyclosporine A
Cyclosporine A is an immunosuppressant drug widely used to prevent organ transplant rejection and treat certain autoimmune diseases.
-
B.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
C.
methotrexate
Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
-
D.
sulfasalazine
Sulfasalazine is an anti-inflammatory drug commonly used to treat rheumatoid arthritis and inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.
-
E.
indoximod
Indoximod is an investigational small-molecule immunotherapy drug that modulates the IDO pathway to enhance anti-tumor immune responses in cancer treatment.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.